{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:05:13Z","timestamp":1789643113972,"version":"4.0.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001582","name":"Dermatology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001582","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jaad.2026.06.111","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T15:43:15Z","timestamp":1782574995000},"page":"1053-1060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low-dose long-term capecitabine for refractory field cancerization: A retrospective cohort study"],"prefix":"10.1016","volume":"95","author":[{"given":"Haley","family":"Neff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Mortelliti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Karn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeliene","family":"Stump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina A.","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann W.","family":"Silk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily S.","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jaad.2026.06.111_bib1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jaad.2021.03.109","article-title":"United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019","volume":"85","author":"Aggarwal","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2026.06.111_bib2","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.clon.2019.08.005","article-title":"Management of non-melanoma skin cancer in transplant recipients","volume":"31","author":"Collins","year":"2019","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"3","key":"10.1016\/j.jaad.2026.06.111_bib3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jaad.2020.03.126","article-title":"Field cancerization: Definition, epidemiology, risk factors, and outcomes","volume":"83","author":"Willenbrink","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2026.06.111_bib4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1399-0012.2010.01348.x","article-title":"Capecitabine for skin cancer prevention in solid organ transplant recipients","volume":"25","author":"Jirakulaporn","year":"2011","journal-title":"Clinical Transplant"},{"issue":"3","key":"10.1016\/j.jaad.2026.06.111_bib5","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaad.2020.03.127","article-title":"Field cancerization: treatment","volume":"83","author":"Cornejo","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2026.06.111_bib6","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jamadermatol.2020.2327","article-title":"Evaluation of the use of capecitabine for the treatment and prevention of actinic keratoses, squamous cell carcinoma, and basal cell carcinoma: a systematic review","volume":"156","author":"Schauder","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2026.06.111_bib7","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jdcr.2015.09.009","article-title":"Capecitabine for squamous cell carcinoma reduction in solid organ transplant recipients","volume":"1","author":"Breithaupt","year":"2015","journal-title":"JAAD Case Rep"},{"issue":"10","key":"10.1016\/j.jaad.2026.06.111_bib8","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/j.1524-4725.2009.01277.x","article-title":"Management of carcinoma of the skin in solid organ transplant recipients with oral capecitabine","volume":"35","author":"Endrizzi","year":"2009","journal-title":"Dermatol Surg"},{"issue":"4","key":"10.1016\/j.jaad.2026.06.111_bib9","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/dsu.12049","article-title":"Capecitabine to reduce nonmelanoma skin carcinoma burden in solid organ transplant recipients","volume":"39","author":"Endrizzi","year":"2013","journal-title":"Dermatol Surg"},{"issue":"103208","key":"10.1016\/j.jaad.2026.06.111_bib10","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"2","key":"10.1016\/j.jaad.2026.06.111_bib11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"5","key":"10.1016\/j.jaad.2026.06.111_bib12","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/archfaci.8.5.314","article-title":"Validation of a quality-of-life instrument for patients with nonmelanoma skin cancer","volume":"8","author":"Rhee","year":"2006","journal-title":"Arch Facial Plast Surg"},{"key":"10.1016\/j.jaad.2026.06.111_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaad.2025.12.027","article-title":"Understanding factors impacting quality of life in patients with keratinocyte carcinoma: A cross-sectional analysis of Mohs surgery patients","volume":"95","author":"Fagan","year":"2026","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.06.111_bib14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jdrv.2025.04.006","article-title":"Cancer-related fatigue in dermatologic surgery","volume":"5","author":"Jing","year":"2025","journal-title":"JAAD Rev"},{"issue":"11","key":"10.1016\/j.jaad.2026.06.111_bib15","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/jamadermatol.2025.3238","article-title":"Nicotinamide for skin cancer chemoprevention","volume":"161","author":"Breglio","year":"2025","journal-title":"JAMA Dermatol"},{"issue":"17","key":"10.1016\/j.jaad.2026.06.111_bib16","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1506197","article-title":"A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention","volume":"373","author":"Chen","year":"2015","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jaad.2026.06.111_bib17","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1200\/JCO.1995.13.8.1933","article-title":"Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study","volume":"13","author":"Bavinck","year":"1995","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jaad.2026.06.111_bib18","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jaad.2023.11.034","article-title":"Effectiveness of acitretin for skin cancer prevention in immunosuppressed and nonimmunosuppressed patients: a retrospective cohort study","volume":"90","author":"Bhullar","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2026.06.111_bib19","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jaad.2025.11.057","article-title":"Chemoprophylactic effect of PD-1\/PD-L1 inhibitor treatment on non-melanoma skin cancer development","volume":"94","author":"Schneider","year":"2026","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2026.06.111_bib20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/jamadermatol.2024.5750","article-title":"Immune checkpoint inhibitors in field cancerization and keratinocyte cancer prevention","volume":"161","author":"Cox","year":"2025","journal-title":"JAMA Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226030069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226030069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:59:47Z","timestamp":1789642787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226030069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0190962226030069"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.06.111","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-dose long-term capecitabine for refractory field cancerization: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.06.111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}